| 000 | 01333 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250515044828.0 | ||
| 264 | 0 | _c20070111 | |
| 008 | 200701s 0 0 eng d | ||
| 022 | _a1812-9269 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMizutani, K | |
| 245 | 0 | 0 |
_aExpression of clusterin, XIAP and survivin, and their changes by camptothecin (CPT) treatment in CPT-resistant PC-3 and CPT-sensitive LNCaP cells. _h[electronic resource] |
| 260 |
_bExperimental oncology _cSep 2006 |
||
| 300 |
_a209-15 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xpharmacology |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 |
_aCamptothecin _xpharmacology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aClusterin _xanalysis |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInhibitor of Apoptosis Proteins _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMicrotubule-Associated Proteins _xanalysis |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xanalysis |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xgenetics |
| 650 | 0 | 4 | _aSurvivin |
| 650 | 0 | 4 |
_aX-Linked Inhibitor of Apoptosis Protein _xanalysis |
| 700 | 1 | _aMatsumoto, K | |
| 700 | 1 | _aHasegawa, N | |
| 700 | 1 | _aDeguchi, T | |
| 700 | 1 | _aNozawa, Y | |
| 773 | 0 |
_tExperimental oncology _gvol. 28 _gno. 3 _gp. 209-15 |
|
| 999 |
_c16653889 _d16653889 |
||